These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 3199816)
1. Role of estrogen receptors and antiestrogen binding sites in an early effect of antiestrogens, the inhibition of cholesterol biosynthesis. Cypriani B; Tabacik C; Descomps B; Crastes de Paulet A J Steroid Biochem; 1988 Nov; 31(5):763-71. PubMed ID: 3199816 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of estrogen receptor, antiestrogen binding sites and calmodulin for antiestrogen resistance of two clones derived from the MCF-7 breast cancer cell line. Borras M; Jin L; Bouhoute A; Legros N; Leclercq G Biochem Pharmacol; 1994 Nov; 48(11):2015-24. PubMed ID: 7802690 [TBL] [Abstract][Full Text] [Related]
3. Possible mechanisms for the agonist actions of tamoxifen and the antagonist actions of MER-25 (ethamoxytriphetol) in the mouse uterus. Lyman SD; Jordan VC Biochem Pharmacol; 1985 Aug; 34(15):2795-806. PubMed ID: 4015716 [TBL] [Abstract][Full Text] [Related]
4. [Effects of antiestrogens and medroxyprogesterone acetate on the clonogenic growth of tamoxifen-sensitive and resistant human breast cancer cells]. Nomura Y; Tashiro H; Takaeko F Gan To Kagaku Ryoho; 1985 Apr; 12(4):844-50. PubMed ID: 3157351 [TBL] [Abstract][Full Text] [Related]
5. Differential effects of estrogen and antiestrogen on transforming growth factor gene expression in endometrial adenocarcinoma cells. Gong Y; Ballejo G; Murphy LC; Murphy LJ Cancer Res; 1992 Apr; 52(7):1704-9. PubMed ID: 1551100 [TBL] [Abstract][Full Text] [Related]
6. Physicochemical and genetic evidence for specific antiestrogen binding sites. Faye JC; Jozan S; Redeuilh G; Baulieu EE; Bayard F Proc Natl Acad Sci U S A; 1983 Jun; 80(11):3158-62. PubMed ID: 6574477 [TBL] [Abstract][Full Text] [Related]
7. The pure antiestrogen ICI 182,780 binds to a high-affinity site distinct from the estrogen receptor. Parisot JP; Hu XF; Sutherland RL; Wakeling A; Zalcberg JR; DeLuise M Int J Cancer; 1995 Aug; 62(4):480-4. PubMed ID: 7635575 [TBL] [Abstract][Full Text] [Related]
8. Antiestrogen binding site and estrogen receptor mediate uptake and distribution of 4-hydroxytamoxifen-targeted doxorubicin-formaldehyde conjugate in breast cancer cells. Burke PJ; Kalet BT; Koch TH J Med Chem; 2004 Dec; 47(26):6509-18. PubMed ID: 15588086 [TBL] [Abstract][Full Text] [Related]
9. Induction of two estrogen-responsive proteins by antiestrogens in R27, a tamoxifen-resistant clone of MCF7 cells. Vignon F; Lippman ME; Nawata H; Derocq D; Rochefort H Cancer Res; 1984 May; 44(5):2084-8. PubMed ID: 6713400 [TBL] [Abstract][Full Text] [Related]
10. [Effects of estrogen and endocrine therapeutic agents on the estrogen receptor, progesterone receptor and DNA synthesis in MCF-7 human breast cancer cells using the whole cell uptake method]. Kurebayashi J; Horiuchi R; Nakamura T; Iino Y; Ishida T; Takigawa H; Izuo M Nihon Naibunpi Gakkai Zasshi; 1987 Nov; 63(11):1351-63. PubMed ID: 2965035 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of the uterotropic activity of estrogens and antiestrogens by the short acting antiestrogen LY117018. Jordan VC; Gosden B Endocrinology; 1983 Aug; 113(2):463-8. PubMed ID: 6872937 [TBL] [Abstract][Full Text] [Related]
12. Antitumor action of physiological estradiol on tamoxifen-stimulated breast tumors grown in athymic mice. Yao K; Lee ES; Bentrem DJ; England G; Schafer JI; O'Regan RM; Jordan VC Clin Cancer Res; 2000 May; 6(5):2028-36. PubMed ID: 10815929 [TBL] [Abstract][Full Text] [Related]
13. Estrogen receptor-mediated and cytotoxic effects of the antiestrogens tamoxifen and 4-hydroxytamoxifen. Taylor CM; Blanchard B; Zava DT Cancer Res; 1984 Apr; 44(4):1409-14. PubMed ID: 6704959 [TBL] [Abstract][Full Text] [Related]
14. Differential antiestrogen action in the immature rat uterus: a comparison of hydroxylated antiestrogens with high affinity for the estrogen receptor. Jordan VC; Gosden B J Steroid Biochem; 1983 Sep; 19(3):1249-58. PubMed ID: 6684713 [TBL] [Abstract][Full Text] [Related]
15. Comparison of the physicochemical properties of uterine nuclear estrogen receptors bound to estradiol or 4-hydroxytamoxifen. Attardi B; Happe HK Endocrinology; 1986 Aug; 119(2):904-15. PubMed ID: 3732150 [TBL] [Abstract][Full Text] [Related]
16. An evaluation of the role of antiestrogen-binding sites in mediating the growth modulatory effects of antiestrogens: studies using t-butylphenoxyethyl diethylamine, a compound lacking affinity for the estrogen receptor. Sheen YY; Simpson DM; Katzenellenbogen BS Endocrinology; 1985 Aug; 117(2):561-4. PubMed ID: 4017947 [TBL] [Abstract][Full Text] [Related]
17. Disparate effects of triphenylethylene antiestrogens on estrogen and progestin biosyntheses by cultured rat granulosa cells. Welsh TH; Jia XC; Jones PB; Zhuang LZ; Hsueh AJ Endocrinology; 1984 Oct; 115(4):1275-82. PubMed ID: 6434288 [TBL] [Abstract][Full Text] [Related]
18. Antiestrogen binding in antiestrogen growth-resistant estrogen-responsive clonal variants of MCF-7 human breast cancer cells. Miller MA; Lippman ME; Katzenellenbogen BS Cancer Res; 1984 Nov; 44(11):5038-45. PubMed ID: 6488162 [TBL] [Abstract][Full Text] [Related]
20. The antiproliferative effect of tamoxifen in breast cancer cells: mediation by the estrogen receptor. Bardon S; Vignon F; Derocq D; Rochefort H Mol Cell Endocrinol; 1984 May; 35(2-3):89-96. PubMed ID: 6734930 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]